Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
University of Michigan Rogel Cancer Center
Hospital Universitari de Bellvitge
Ohio State University Comprehensive Cancer Center
University of California, San Francisco
University of Washington
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
NRG Oncology
Roswell Park Cancer Institute
University of California, San Francisco
Mayo Clinic
Wake Forest University Health Sciences
University of Washington
University of Washington
University of Washington
Roswell Park Cancer Institute
NRG Oncology
University of California, San Francisco
Vanderbilt-Ingram Cancer Center
Jonsson Comprehensive Cancer Center
Mayo Clinic
Ohio State University Comprehensive Cancer Center
OHSU Knight Cancer Institute
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
City of Hope Medical Center
Northwestern University
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Northwestern University
Northwestern University
IRCCS San Raffaele
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Medical University of Vienna
Centre Hospitalier Universitaire Dijon
University of Kansas Medical Center